Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Metadata
Title
Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
Author
Philip B. Mitchell
Publication date
01-12-1997
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 6/1997
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199717060-00005

Other articles of this Issue 6/1997

Drug Safety 6/1997 Go to the issue

Leading Article

Causal or Casual?

Leading Article

Nonsteroidal Anti-Inflammatory Drugs and Necrotising Fasciitis

Current Opinion

Levonorgestrel Subdermal Implants

Review Articles

A Risk-Benefit Assessment of Iron-Chelation Therapy